Incremental progress but still far from good enough: real-world LDL-cholesterol insights from the SANTORINI 1-year follow-up study

Mayank Dalakoti^{1

2

3}, Denis Angoulvant^{4

5}

Affiliations

¹ Department of Cardiology, National University Heart Centre, Cambridge, Singapore.
² Cardiovascular Metabolic Disease Translational Research Program, National University of Singapore, Singapore.
³ Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
⁴ Service de Cardiologie, Centre Hospitalier Régional Universitaire et Faculté de Médecine de Tours, 37000 Tours, France.
⁵ UMR Inserm 1327 ISCHEMIA, 'Membrane signaling and Inflammation in reperfusion injuries', Université de Tours, F37000 Tours, France.

Editorial

Mayank Dalakoti et al. Eur J Prev Cardiol. 2024.

. 2024 Nov 11;31(15):1804-1805.

doi: 10.1093/eurjpc/zwae213.

Mayank Dalakoti^{1

2

3}, Denis Angoulvant^{4

5}

¹ Department of Cardiology, National University Heart Centre, Cambridge, Singapore.
² Cardiovascular Metabolic Disease Translational Research Program, National University of Singapore, Singapore.
³ Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
⁴ Service de Cardiologie, Centre Hospitalier Régional Universitaire et Faculté de Médecine de Tours, 37000 Tours, France.
⁵ UMR Inserm 1327 ISCHEMIA, 'Membrane signaling and Inflammation in reperfusion injuries', Université de Tours, F37000 Tours, France.

No abstract available

Conflict of interest statement

Conflict of interest: none declared.

Use of combination therapy is associated with improved LDL cholesterol management: 1-year follow-up results from the European observational SANTORINI study.
Ray KK, Aguiar C, Arca M, Connolly DL, Eriksson M, Ferrières J, Laufs U, Mostaza JM, Nanchen D, Bardet A, Lamparter M, Chhabra R, Soronen J, Rietzschel E, Strandberg T, Toplak H, Visseren FLJ, Catapano AL; SANTORINI Study Investigators. Ray KK, et al. Eur J Prev Cardiol. 2024 Nov 11;31(15):1792-1803. doi: 10.1093/eurjpc/zwae199. Eur J Prev Cardiol. 2024. PMID: 38861400